Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
Lowest Published Lethal Dose:
LDL [Rat - Route: oral; Dose: 7500 mg/kg
LDL Rabbit - Route: Oral; Dose: 5000 mg/kg
LDL Dog - Rout: Oral; Dose: 5000 mg/kg
Lethal Dose/Conc 50% kill:
LD50 Mouse - Route: Intravenous; Dose: 485 mg/kgL50221
Other Toxic Effects on Humans:
Acute Potential Health Effects:
Skin: Causes skin irritation
Eyes: Causes eye irritation
Inhalation: Causes respiratory tract irritation
Ingestion: Causes gastrointestinal tract irritation with nausea, vomiting and diarrhea. May affect kidneys (kidney
damage), blood, and behavior (convulsions, somnolence), and respiration.
Chronic Potential Health Effects:
Ingestion: Repeated or prolonged ingestion may cause lesions of the mouth, gastric ulcers, gastrointestinal
hyperacidity, and symptoms similar to those of metal fume fever - flu-like condition with fever, chills, sweats,
nausea, vomiting, muscle aches, pains, and weakness.
Skin: Repeated or prolonged skin contact may cause skin ulcerations or lesions.
Tartaric acid is a white crystalline organic acid that occurs naturally in many plants, most notably in grapes.Tartaric is an alpha-hydroxy-carboxylic acid, is diprotic and aldaric in acid characteristics, and is a dihydroxyl derivative of succinic acid.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Technetium Tc-99m oxidronate | L-tartaric acid may decrease effectiveness of Technetium Tc-99m oxidronate as a diagnostic agent. |
| Amphetamine | The excretion of Amphetamine can be decreased when combined with L-tartaric acid. |
| Phentermine | The excretion of Phentermine can be decreased when combined with L-tartaric acid. |
| Pseudoephedrine | The excretion of Pseudoephedrine can be decreased when combined with L-tartaric acid. |
| Benzphetamine | The excretion of Benzphetamine can be decreased when combined with L-tartaric acid. |
| Diethylpropion | The excretion of Diethylpropion can be decreased when combined with L-tartaric acid. |
| Lisdexamfetamine | The serum concentration of Lisdexamfetamine can be increased when it is combined with L-tartaric acid. |
| Mephentermine | The excretion of Mephentermine can be decreased when combined with L-tartaric acid. |
| MMDA | The excretion of MMDA can be decreased when combined with L-tartaric acid. |
| Midomafetamine | The excretion of Midomafetamine can be decreased when combined with L-tartaric acid. |
| 2,5-Dimethoxy-4-ethylamphetamine | The excretion of 2,5-Dimethoxy-4-ethylamphetamine can be decreased when combined with L-tartaric acid. |
| 4-Bromo-2,5-dimethoxyamphetamine | The excretion of 4-Bromo-2,5-dimethoxyamphetamine can be decreased when combined with L-tartaric acid. |
| Tenamfetamine | The excretion of Tenamfetamine can be decreased when combined with L-tartaric acid. |
| Chlorphentermine | The excretion of Chlorphentermine can be decreased when combined with L-tartaric acid. |
| Methylenedioxyethamphetamine | The excretion of Methylenedioxyethamphetamine can be decreased when combined with L-tartaric acid. |
| Dextroamphetamine | The excretion of Dextroamphetamine can be decreased when combined with L-tartaric acid. |
| Metamfetamine | The excretion of Metamfetamine can be decreased when combined with L-tartaric acid. |
| Iofetamine I-123 | The excretion of Iofetamine I-123 can be decreased when combined with L-tartaric acid. |
| Ritobegron | The excretion of Ritobegron can be decreased when combined with L-tartaric acid. |
| Mephedrone | The excretion of Mephedrone can be decreased when combined with L-tartaric acid. |
| Methoxyphenamine | The excretion of Methoxyphenamine can be decreased when combined with L-tartaric acid. |
| Gepefrine | The excretion of Gepefrine can be decreased when combined with L-tartaric acid. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | The excretion of 2,5-Dimethoxy-4-ethylthioamphetamine can be decreased when combined with L-tartaric acid. |
| Phendimetrazine | The excretion of Phendimetrazine can be decreased when combined with L-tartaric acid. |
| Doxycycline | The therapeutic efficacy of Doxycycline can be decreased when used in combination with L-tartaric acid. |
| Lymecycline | The therapeutic efficacy of Lymecycline can be decreased when used in combination with L-tartaric acid. |
| Clomocycline | The therapeutic efficacy of Clomocycline can be decreased when used in combination with L-tartaric acid. |
| Tigecycline | The therapeutic efficacy of Tigecycline can be decreased when used in combination with L-tartaric acid. |
| Oxytetracycline | The therapeutic efficacy of Oxytetracycline can be decreased when used in combination with L-tartaric acid. |
| Demeclocycline | The therapeutic efficacy of Demeclocycline can be decreased when used in combination with L-tartaric acid. |
| Tetracycline | The therapeutic efficacy of Tetracycline can be decreased when used in combination with L-tartaric acid. |
| Metacycline | The therapeutic efficacy of Metacycline can be decreased when used in combination with L-tartaric acid. |
| Minocycline | The therapeutic efficacy of Minocycline can be decreased when used in combination with L-tartaric acid. |
| Rolitetracycline | The therapeutic efficacy of Rolitetracycline can be decreased when used in combination with L-tartaric acid. |
| Sarecycline | The therapeutic efficacy of Sarecycline can be decreased when used in combination with L-tartaric acid. |
| Eravacycline | The therapeutic efficacy of Eravacycline can be decreased when used in combination with L-tartaric acid. |
| Omadacycline | The therapeutic efficacy of Omadacycline can be decreased when used in combination with L-tartaric acid. |
| Penimepicycline | The therapeutic efficacy of Penimepicycline can be decreased when used in combination with L-tartaric acid. |
| Memantine | The excretion of Memantine can be decreased when combined with L-tartaric acid. |